Chester County News and Community Website
BRISTOL, PA — 1SEO Digital Agency has appointed Paul Carmody as its new Chief Executive Officer, signaling a strategic move to accelerate growth and enhance service delivery across key sectors. …
Paul Carmody Named CEO of 1SEO Digital Agency, Poised to Drive Next Phase of Growth Read More
LANGHORNE, PA — Dermalign Medical Aesthetics is setting a new benchmark for non-surgical facial rejuvenation under the leadership of board-certified Physician Associate Ekata Rushi, PA-C. Drawing on over a decade …
Dermalign Medical Aesthetics Redefines Non-Surgical Rejuvenation in Bucks and Montgomery Counties Read More
HARRISBURG, PA — The Pennsylvania Department of Community and Economic Development (DCED) has approved a $1 million low-interest loan through the Pennsylvania Industrial Development Authority (PIDA) to support expansion and …
$1 Million State Loan to Boost Bucks County Manufacturing, Create New Jobs Read More
WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) announced that the U.S. Patent and Trademark Office has issued a new patent covering its lead investigational therapy, istaroxime, for intravenous treatment …
Windtree Therapeutics Secures U.S. Patent for Istaroxime Heart Failure Treatment Read More
LANGHORNE, PA — TEN Holdings, Inc. (NASDAQ: XHLD) has announced the appointment of Virgilio D. Torres as its new Chief Financial Officer. Torres brings extensive experience in corporate finance, mergers …
TEN Holdings Appoints Virgilio D. Torres as Chief Financial Officer Read More WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has achieved a major milestone in its Phase 2 SEISMiC C study, announcing the planned enrollment of 20 patients for its interim …
Windtree Therapeutics Advances Istaroxime Phase 2 Study with Interim Analysis Enrollment Read More
DOYLESTOWN, PA — Metabolics Pharma has announced preclinical findings highlighting the unique benefits of its drug candidate, ENT-03, in treating obesity and related metabolic dysfunctions. The study revealed that ENT-03 …
Metabolics Pharma’s ENT-03 Shows Promise in Obesity Treatment Read More
DOYLESTOWN, PA — Powerlytics has announced the launch of its TrueWealth platform, a groundbreaking innovation poised to revolutionize how wealth management firms, banks, credit unions, and lenders identify and engage …
Powerlytics Unveils TrueWealth, Redefining Prospecting for Financial Institutions Read More
DOYLESTOWN, PA — Metabolics Pharma has announced top-line results from a Phase 1a clinical trial of ENT-03, its investigational drug for obese and diabetic patients. The trial demonstrated that ENT-03 …
Metabolics Pharma Reports Promising Phase 1a Results for ENT-03 Read More
NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) has announced a 1-for-50 reverse split of its Class A common stock, set to take effect at 5:00 pm Eastern time …
Helius Medical Announces 1-for-50 Reverse Stock Split Read More